alzheimers

Interview with Husseini K. Manji, MD, author of The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review. Hosted by John Torous, MD.

Curated By Nelson Vergel, Update: June 2026 For decades, dementia was viewed as an unavoidable consequence of aging. Patients and families often faced a diagnosis with few treatment options and little hope beyond symptom management. Today, that paradigm is changing rapidly. Advances in...

At the Longevity Forum Science Summit, Professor Ruth Itzhaki delivered a groundbreaking talk exploring the long-suspected but often controversial link between herpes simplex virus type 1 (HSV-1) and Alzheimer’s disease. Drawing on more than three decades of research, she explained how HSV-1 can...

Abstract Aim We previously reported that oxytocin, a peptide hormone, can reverse the β-amyloid peptide (25–35) (Aβ25–35)-induced impairments of the murine hippocampal synaptic plasticity. In this study, we examined the effects of oxytocin on the Aβ25–35-induced impairment of cognitive behavior...